Hubei Jumpcan Pharmaceutical Co Ltd
SSE:600566
Intrinsic Value
The intrinsic value of one Hubei Jumpcan Pharmaceutical Co Ltd stock under the Base Case scenario is 45.09 CNY. Compared to the current market price of 26.16 CNY, Hubei Jumpcan Pharmaceutical Co Ltd is Undervalued by 42%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Hubei Jumpcan Pharmaceutical Co Ltd
Fundamental Analysis

Revenue & Expenses Breakdown
Hubei Jumpcan Pharmaceutical Co Ltd
Balance Sheet Decomposition
Hubei Jumpcan Pharmaceutical Co Ltd
Current Assets | 14.3B |
Cash & Short-Term Investments | 11.7B |
Receivables | 1.9B |
Other Current Assets | 713.7m |
Non-Current Assets | 3.8B |
Long-Term Investments | 453.7m |
PP&E | 2.8B |
Intangibles | 481.6m |
Other Non-Current Assets | 110m |
Free Cash Flow Analysis
Hubei Jumpcan Pharmaceutical Co Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Hubei Jumpcan Pharmaceutical Co Ltd
Revenue
|
8.9B
CNY
|
Cost of Revenue
|
-1.9B
CNY
|
Gross Profit
|
7B
CNY
|
Operating Expenses
|
-4.3B
CNY
|
Operating Income
|
2.7B
CNY
|
Other Expenses
|
42.5m
CNY
|
Net Income
|
2.8B
CNY
|
Profitability Score
Profitability Due Diligence
Hubei Jumpcan Pharmaceutical Co Ltd's profitability score is 76/100. The higher the profitability score, the more profitable the company is.
Score
Hubei Jumpcan Pharmaceutical Co Ltd's profitability score is 76/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Hubei Jumpcan Pharmaceutical Co Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.
Score
Hubei Jumpcan Pharmaceutical Co Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Hubei Jumpcan Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Hubei Jumpcan Pharmaceutical Co Ltd is 53.41 CNY with a low forecast of 52.88 CNY and a high forecast of 54.98 CNY.
Dividends
Current shareholder yield for Hubei Jumpcan Pharmaceutical Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one Hubei Jumpcan Pharmaceutical Co Ltd stock under the Base Case scenario is 45.09 CNY.
Compared to the current market price of 26.16 CNY, Hubei Jumpcan Pharmaceutical Co Ltd is Undervalued by 42%.